US-Based Apollo Endosurgery’s Product to Treat Obesity Gets USFDA Approval

by Reshma Anand on  August 12, 2015 at 3:10 PM Obesity News   - G J E 4
Apollo introduces a minimally invasive gastrointestinal balloon to combat obesity that has been approved by the FDA.
US-Based Apollo Endosurgery’s Product to Treat Obesity Gets USFDA Approval
US-Based Apollo Endosurgery’s Product to Treat Obesity Gets USFDA Approval

Dennis McWilliams, Apollo's president and CEO, said, "the device is a sort of mid-point therapy to combat obesity, in between diet and exercise, and more invasive procedures such as gastric bypass surgery. This helps us build a suite of products for the treatment of obesity."

"Less than 1% of total population with obesity that is eligible for surgical intervention is getting treatment. This is like for cardiovascular patients waiting until a heart attack to get treated for heart disease," he added.

Apollo specializes in trans-lumenal surgery, therapeutic endoscopy, and minimally invasive devices for GI procedures. Orbera is used in about 80 countries in more than 200,000 procedures around the world and it was a part of the product line.

Deflated Orbera balloon is inserted through a patient's throat using a catheter. Then it is inflated to the size of a grapefruit and filled with saline. The procedure takes about 30 minutes under a mild sedative and the patients can go home the same day. The balloon is deflated and removed in a similar procedure to its insertion after 6 months.

"The stomach is designed to expel things; it's working really hard to push this object out. That's what leads to the time limit of these devices," said McWilliams.

"Obesity is a complex disease. A mechanical aid like a balloon can retrain them how to eat effectively. The idea is to help patients stay motivated, work through any weight-loss barriers they have and create healthy habits that will last well beyond the device's lifetime," he added.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

View All